AsymmetRx Must Add Harvard To IP Suit: Fed. Circ.
The U.S. Court of Appeals for the Federal Circuit on Friday vacated the district court’s grant of summary judgment against AsymmetRx after determining that Harvard did not convey the entire right to enforce the two patents-in-suit to AsymmetRx.
“Because we find that AsymmetRx may pursue its infringement...
To view the full article, register now.